Study to Assess the Risk of Blood Borne Transmission of Classic Forms of Creutzfeldt-Jakob Disease (CJD)
ArchivedCenters for Disease Control and Prevention - ERA
Description
The purpose of this Notice of Funding Opportunity is to enable the continuation of the active, nationwide study, begun in 1995, of recipients of blood products from donors who are subsequently diagnosed with classic forms of Creutzfeldt-Jakob Disease (CJD) in order to assess the risk of possible transmission of such forms of CJD by blood transfusion.
Who can apply
- Others
Contact
Deborah Loveys<br/>hft6@cdc.gov
hft6@cdc.gov
Key dates & funding
- PostedNov 28, 2018
- ClosesMar 19, 2019
- Award floor$70,000
- Award ceiling$77,000
- Program funding$385,000
- Expected awards1
- CFDA93.084
Categories
Pro insight
Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.
Unlock with Pro